Navigation Links
Initiation of Coverage Informational Review Issued by Scimitar Equity Research
Date:12/17/2007

BOSTON, Dec. 17 /PRNewswire/ -- Scimitar Equity Research, Inc. issues a review on Nventa Biopharmaceuticals Corporation (TSX: NVN) entitled: "A Very Promising Therapeutic and Vaccine Candidate for the Treatment of Diseases Caused by the Human Papillomavirus (HPV)." The analyst research is available on Scimitar's website: http://www.scimitarequity.com.

About Nventa Corporation:

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Exchange under the symbol NVN. For more information about Nventa, please visit http://www.nventacorp.com.

About HspE7, Nventa's Lead Product Candidate:

HspE7 is a novel therapeutic vaccine candidate for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. HspE7 is derived from Nventa's proprietary CoVal(TM) fusion platform, which uses recombinant DNA technology to covalently fuse stress proteins to target antigens, thereby stimulating cellular immune system responses. Heat shock proteins (Hsps), also known as stress proteins, are naturally present in the human body and play important roles in the immune system, including transporting substances within cells and activating cells of the immune system.

Scimitar Equity Research, Inc. provides equity research of emerging healthcare companies for the institutional and investment communities. We certify that all the views expressed in this review, accurately reflect our personal views about NVN.TO (TSX) and its or their securities. No part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views contained in this review and we will not have any inve
'/>"/>

SOURCE Scimitar Equity Research, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
4. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
5. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
8. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
9. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... and MELVILLE, N.Y. , ... CAH ), one of the world,s largest health ... HSIC ), the world,s largest provider of health ... and medical practitioners, today announced that the companies have ... of the most comprehensive service and product offerings to ...
(Date:11/21/2014)... LAVAL, QC , Nov. 20, 2014 /CNW Telbec/ ... pleased to announce the following appointments: ... leadership team in the newly created role of Chief ... a BioPhotonic system using topical photoconverter gel for the ... as surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... BEVERLY HILLS, Calif. , Nov. 20, 2014 ... Ken Eaton , the election of Anthony J. ... as President. Effective November 19, 2014, ... and member of the Board of Directors of Oxis International, ... J. Cataldo has been named Chief Executive Officer of ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... Oct. 11 ECRI Institute® ( www.ecri.org ), an ... improving patient care, is pleased to announce Kaiser Permanente ... health plan,  as the winner of the 5th annual ... health technology management. The Health Devices Achievement Award ...
... N.C., Oct. 11 Talecris Biotherapeutics Holdings Corp. (Nasdaq: ... release before the market opens on October 28, 2010. Due ... be hosting a conference call to discuss its third quarter ... Inspiration. Dedication. Innovation. Talecris Biotherapeutics is ...
Cached Medicine Technology:ECRI Institute Names Kaiser Permanente Winner of 5th Annual Health Devices Achievement Award 2ECRI Institute Names Kaiser Permanente Winner of 5th Annual Health Devices Achievement Award 3
(Date:11/22/2014)... month has been a historical time for Angeldress.co.uk, an excellent ... from some renowned review websites. Recently, the company has added ... selection of wonderful sexy wedding dresses to its website. At ... up to an 80% discount on any order over GBP ... suitable dress at Angeldress.co.uk, which has garnered a hard core ...
(Date:11/22/2014)... 22, 2014 The Sports Conflict Institute ... Baroff to its team of conflict resolution professionals. Baroff ... coach, and referee. He has over 30 years experience as ... , “I'm very excited to connect with SCI and bring ... interests to a program with a complete sports focus,” says ...
(Date:11/22/2014)... 22, 2014 “Greenfield Naturals” was featured ... Report , which features the latest and coolest technology ... and reporter for NewsWatch, conducted the product review and ... flavor of your water. , From pollution to hazardous ... that everything is done to remove these chemicals, especially ...
(Date:11/22/2014)... 2014 (HealthDay News) -- Many young people consider hookahs ... new study finds fumes from the water pipes contain ... an increased risk for leukemia in prior research, according ... journal Cancer Epidemiology, Biomarkers & Prevention . ... is not a safe alternative to smoking other forms ...
(Date:11/22/2014)... Norton HealthDay Reporter FRIDAY, ... in nursing homes may commonly deal with aggressive or inappropriate ... study of 10 centers in New York state found that, ... of residents were involved in some type of incident with ... clash, with someone yelling or cursing at another resident. In ...
Breaking Medicine News(10 mins):Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 3
... by postdoc Luke Holman of the Center for Social Evolution, ... published on the 24 February 2010, that ant queens are ... ant colony has more than one queen. Multiple queens can ... chance the colony will survive the hazardous first year. But ...
... ... that can be instantly priced and ordered online and offline. , ... Ft. Scott, KS (PRWEB) February 25, ... and services, today announced the launch of their LaserBand® printable wristbands offering. The offering ...
... will be passed anytime soon , THURSDAY, Feb. 25 ... reform, President Barack Obama on Thursday will hold a ... Americans who tune in to watch is whether anything ... that Obama start from scratch and some Democrats conceding ...
... ... ... Advans, a solution provider and IT consulting firm, has announced today, the results of ... IT Outsourcing Survey, 75 percent of executives prefer outsourcing domestically rather than offshore. ...
... The Public ... fall, with most of these falls occurring within their own home during daily activities. Elderly ... medical alert equipment in the industry as LifeCall introduces the LifeCall 9000 device. , ... (PRWEB) February 25, 2010 -- The ...
... ... are falling apart at home, psychotherapeutic interventions provide families with a growing array of options. ... (PRWEB) February 25, 2010 ... falling apart at home, psychotherapeutic interventions provide families with a growing array of options., , ...
Cached Medicine News:Health News:Plotting and treachery in ant royal families 2Health News:My1Stop.com Expands Into Medical Wristbands Market with Patented LaserBand Printable Wristbands 2Health News:My1Stop.com Expands Into Medical Wristbands Market with Patented LaserBand Printable Wristbands 3Health News:As Health Reform Summit Looms, Battle Lines Are Drawn 2Health News:As Health Reform Summit Looms, Battle Lines Are Drawn 3Health News:As Health Reform Summit Looms, Battle Lines Are Drawn 4Health News:Advans Survey Reveals that 75 Percent of Executives Prefer Domestic Outsourcing vs. Offshore 2Health News:Innovative Medical Alert Device Sets a New Standard in PERS Industry 2Health News:New Approaches to Teen Therapy Bring Results 2Health News:New Approaches to Teen Therapy Bring Results 3Health News:New Approaches to Teen Therapy Bring Results 4Health News:New Approaches to Teen Therapy Bring Results 5
The GII titanium anchor is the "Gold Standard" for soft tissue reattachment to bone. The GII's small size, high pull-out strength and wide range of clinical applications make it the anchor of choice ...
... Proxis features 'proximal protection' -- providing ... removal, even in vessels with side branches. ... to use. It does not require the ... removal of embolic debris. ,Proxis is ...
... Single Plane Imaging System is the Fischer ... for the electrophysiology specialist. The EP-X system ... totally integrated and dedicated EP lab system. ... space requirements and Pulsed Progressive Fluoroscopy (PPF) ...
... your office efficiency by reducing errors and ... cardiology software solution, you can spend less ... practice and more time on your patient ... complete practice solution. With over 50,000 installations ...
Medicine Products: